CDC report shows rise in teen COVID hospitalizations
The director of the Centers for Disease Control and Prevention is urging parents to get their teenagers to get vaccinated against COVID-19 amid a spike in hospitalizations. Mola Lenghi has more.
Watch CBS News
The director of the Centers for Disease Control and Prevention is urging parents to get their teenagers to get vaccinated against COVID-19 amid a spike in hospitalizations. Mola Lenghi has more.
Modern has applied for full FDA approval of its COVID-19 vaccine. That would allow it to market the shots directly to consumers. Dr. Neeta Ogden joined CBSN to explain the likely impact as well as new research on potential booster shots and side effects.
The CDC is investigating some rare cases of heart inflammation among vaccinated teens and young adults. The complications were more common in males than in females, and showed up about four days after a second dose of the Moderna and Pfizer vaccines. Lilia Luciano reports.
Researchers are studying COVID-19 vaccinations in kids as young as 6 months old. CBS News correspondent Jamie Yuccas spoke to a family who says they were eager for the opportunity to vaccinate their 3-year-old and 8-month-old and are encouraging others to sign up.
The number of new COVID-19 cases in the U.S. fell below 30,000 for the fifth straight day on Thursday as more people get vaccinated. Dr. Bob Lahita joined CBSN to discuss whether a potential booster shot may be needed by the fall.
President Biden said new data shows nearly 60% of American adults are partially vaccinated. Plus, for the first time since the pandemic began, coronavirus cases are dropping in all 50 states. This all comes as many people are wondering whether it is actually safe to take off your mask. Dr. Jessica Shepherd, the chief medical officer at Verywell Health, joins CBSN's Elaine Quijano to discuss.
While some parents are hesitant to have their kids get the COVID-19 vaccine, others couldn’t wait to get their kids in line. Mola Lenghi shares more.
The Pan American Health Organization warned the misinformation spreading online about the coronavirus pandemic is fueling vaccine hesitancy. CBSN tech reporter Dan Patterson joined "CBSN AM" to discuss how conspiracy theories reach millions of people and why they are so hard to stomp out.
The CDC is recommending Pfizer's COVID-19 vaccine to children as young as 12. As CBS News correspondent Janet Shamlian explains, some hospitals began administering shots to the younger age group prior to the recommendation. Dr. Stanley Perlman, a professor of microbiology and immunology at the University of Iowa and a pediatric infectious diseases physician, shares his analysis.
Many adolescents could get their first doses within the coming days.
Children as young as 12 could start receiving the Pfizer COVID-19 vaccine as soon as Thursday if a CDC advisory panel gives the green light. Janet Shamlian shares more.
President Biden on Tuesday held a meeting with governors to discuss new efforts to combat dwindling vaccine demand as officials prepare to vaccinate millions of adolescents. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joins CBSN's Elaine Quijano to discuss the latest.
The FDA authorized Pfizer's vaccine for emergency use in adolescents between the ages of 12 and 15. The vaccine was found to be 100% effective in that age group. CBS News correspondent David Begnaud reports, and CBSN's Tanya Rivero spoke with Alonzo Plough, the chief science officer at the Robert Wood Johnson Foundation, about what this means for families.
Pfizer's coronavirus vaccine trial of more than 2,200 volunteers ages 12 to 15 showed zero COVID-19 cases among those who were fully vaccinated. CBS News spoke to one teen who was a part of the trial who says, "it's just worth it in every way you look at it." Davd Begnaud reports.
The drugmaker is also conducting clinical trials on their vaccine for babies aged 6 months and older.
Nearly 17 million people will soon become eligible to get the Pfizer COVID-19 vaccine after the FDA authorized its use for children 12 to 15. Dr. William Gruber, Pfizer's Senior Vice President of Vaccine Clinical Research and Development, joins "CBS This Morning" to discuss vaccine safety and other trials Pfizer is conducting.
An analysis that included 1,005 vaccine participants in this age group found the vaccine was 100% effective in preventing COVID-19.
Italian hospital apologizes for lapse on a busy day, but says the young woman has shown no adverse reaction to the overdose of the Pfizer vaccine.
A third of the U.S. population is now fully vaccinated against the coronavirus. But the pace of inoculations is slowing, forcing public health officials to shift their approach. As Janet Shamlian shows us, there are new efforts to expand vaccine access and eligibility. Then, pediatrician Dr. Suzette Oyeku from the Children’s Hospital at Montefiore joins CBSN's Lana Zak with her analysis.
Pfizer has announced that it is officially seeking full Food and Drug Administration approval for its coronavirus vaccine, the first of the three U.S.-approved COVID vaccines being administered under emergency authorization. This as new infections appear to be on the decline, as is demand for vaccines. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
Pfizer is asking the Food and Drug Administration for full approval of its vaccine for people 16 and older. Janet Shamlian has more.
Pfizer is asking the Food and Drug Administration for full approval of its vaccine for people 16 and older.
Pfizer and BioNTech have formally begun the application process to get full approval for their COVID-19 vaccine from the Food and Drug Administration. It would be the first coronavirus vaccine in the U.S. to move past the emergency use stage. Dr. Bob Lahita, director of the Institute for Autoimmune and Rheumatic Diseases at St. Joseph Health, joined CBSN to discuss this and other developments in the fight against the pandemic.
CDC Director Dr. Rochelle Walensky says the U.S. could see a "sharp decline" in new COVID-19 cases by July, as long as people continue to wear masks and get vaccinated. Meanwhile, the Biden administration says it will support the temporary waiver of patent rights to allow developing nations to produce vaccines. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
New data shows both the Moderna and Pfizer vaccines have promising results against COVID-19 variants. John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, joins CBSN's Tanya Rivero for more on the efficacy of COVID vaccines.